Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E Tueni

Phase IB Study of Doxorubicin in Combination With the Multidrug Resistance Reversing Agent S9788 in Advanced Colorectal and Renal Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
1997English

Related publications

Phase I Study of Cinchonine, a Multidrug Resistance Reversing Agent, Combined With the CHVP Regimen in Relapsed and Refractory Lymphoproliferative Syndromes

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer

Investigational New Drugs
OncologyPharmacology
2015English

A Phase-Ii Study of Combination of Pegylated Interferon Alfa-2a and Capecitabine in Locally Advanced or Metastatic Renal Cell Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination With Chemotherapy in Asian Patients With Advanced Solid Tumors: Phase Ib Study

Targeted Oncology
Cancer ResearchOncologyPharmacology
2020English

A Phase Ib/Ii Study of HER3-targeting Lumretuzumab in Combination With Carboplatin and Paclitaxel as First-Line Treatment in Patients With Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2019English

Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

A Phase Ib and Pharmacokinetic Trial of Patupilone Combined With Carboplatin in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Carboplatin in Combination With Epirubicin and Cyclophosphamide in Patients With Advanced Ovarian Cancer: A Phase II Study

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1995English

Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets

Oncologist
Cancer ResearchMedicineOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy